Case Background:
This is a federal securities fraud class action lawsuit on behalf of those who purchased or otherwise acquired Doximity, Inc. (“Doximity”) (NYSE: DOCS) common stock between February 9, 2022 and April 1, 2024, inclusive (the “Class Period”).
The complaint alleges that, throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts, about the company’s business and operations. Specifically, Defendants repeatedly touted Doximity’s business prospects and the sustainability of the company’s revenue growth and profitability, while downplaying the impact of competition and tightening macroeconomic conditions on the company and its reliance on “upselling” products and services (such as additional advertising) to existing customers to sustain its performance and future growth.
Current Status of Case:
On August 12, 2025, Lead Plaintiff filed the Motion for Class Certification. The action is in the discovery phase and is ongoing.
If you wish to discuss this action or have any questions, please contact Kessler Topaz Meltzer & Check, LLP: Jon Naji, Esq. (484) 270-1453; toll-free at (844) 887-9500; or via e-mail at info@ktmc.com. If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.